Mark L. Berch

Array ( [id] => 5285680 [patent_doc_number] => 20090099355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids' [patent_app_type] => utility [patent_app_number] => 11/915241 [patent_app_country] => US [patent_app_date] => 2006-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16612 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099355.pdf [firstpage_image] =>[orig_patent_app_number] => 11915241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786585 [patent_doc_number] => 20060205711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/419756 [patent_app_country] => US [patent_app_date] => 2006-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72181 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205711.pdf [firstpage_image] =>[orig_patent_app_number] => 11419756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416881 [patent_doc_number] => 20090042768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Purine derivatives and their use for treatment of autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 11/919990 [patent_app_country] => US [patent_app_date] => 2006-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9253 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042768.pdf [firstpage_image] =>[orig_patent_app_number] => 11919990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 274379 [patent_doc_number] => 07560545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'Process for obtaining cefotetan with high yield' [patent_app_type] => utility [patent_app_number] => 11/383075 [patent_app_country] => US [patent_app_date] => 2006-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1950 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560545.pdf [firstpage_image] =>[orig_patent_app_number] => 11383075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823203 [patent_doc_number] => 20080227768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Crystal of 1-Methylcarbapenem Compound' [patent_app_type] => utility [patent_app_number] => 11/919932 [patent_app_country] => US [patent_app_date] => 2006-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3927 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227768.pdf [firstpage_image] =>[orig_patent_app_number] => 11919932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534159 [patent_doc_number] => 20090233947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => '2,3-Substituted fused bicyclic pyrimidin-4(3H)-ones which modulating the function of the vanilloid -1 receptor (VR1)' [patent_app_type] => utility [patent_app_number] => 11/920065 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10654 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233947.pdf [firstpage_image] =>[orig_patent_app_number] => 11920065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5890442 [patent_doc_number] => 20060276640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Process for making aztreonam' [patent_app_type] => utility [patent_app_number] => 11/431178 [patent_app_country] => US [patent_app_date] => 2006-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2193 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276640.pdf [firstpage_image] =>[orig_patent_app_number] => 11431178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5787096 [patent_doc_number] => 20060205943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Process for preparing xanthine phosphodiesterase V inhibitors and precursers thereof' [patent_app_type] => utility [patent_app_number] => 11/429719 [patent_app_country] => US [patent_app_date] => 2006-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8488 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205943.pdf [firstpage_image] =>[orig_patent_app_number] => 11429719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279263 [patent_doc_number] => 20090131395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'BIPHENYLAZETIDINONE CHOLESTEROL ABSORPTION INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/913461 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73206 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131395.pdf [firstpage_image] =>[orig_patent_app_number] => 11913461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558851 [patent_doc_number] => 20090270428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'CYCLOPROPANECARBOXYLATE ESTERS OF ACYCLOVIR' [patent_app_type] => utility [patent_app_number] => 11/912350 [patent_app_country] => US [patent_app_date] => 2006-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3236 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270428.pdf [firstpage_image] =>[orig_patent_app_number] => 11912350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 849206 [patent_doc_number] => 07381724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing same' [patent_app_type] => utility [patent_app_number] => 11/416570 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1772 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381724.pdf [firstpage_image] =>[orig_patent_app_number] => 11416570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 191038 [patent_doc_number] => 07642350 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-05 [patent_title] => 'Purine derivatives' [patent_app_type] => utility [patent_app_number] => 11/417982 [patent_app_country] => US [patent_app_date] => 2006-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20146 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/642/07642350.pdf [firstpage_image] =>[orig_patent_app_number] => 11417982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398341 [patent_doc_number] => 20090318404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'SUBSTITUTED BETA-LACTAMS' [patent_app_type] => utility [patent_app_number] => 10/599619 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10672 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318404.pdf [firstpage_image] =>[orig_patent_app_number] => 10599619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904529 [patent_doc_number] => 20080113943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Therapeutic Beta-Lactams' [patent_app_type] => utility [patent_app_number] => 11/569696 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8603 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113943.pdf [firstpage_image] =>[orig_patent_app_number] => 11569696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318736 [patent_doc_number] => 07521446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith' [patent_app_type] => utility [patent_app_number] => 11/411413 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34372 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521446.pdf [firstpage_image] =>[orig_patent_app_number] => 11411413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643460 [patent_doc_number] => 20060281915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Acid cefotetan totally solvent-free and method for obtaining same' [patent_app_type] => utility [patent_app_number] => 11/410022 [patent_app_country] => US [patent_app_date] => 2006-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1331 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281915.pdf [firstpage_image] =>[orig_patent_app_number] => 11410022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1077115 [patent_doc_number] => 07615631 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Crystalline solvate of cefuroxime acid' [patent_app_type] => utility [patent_app_number] => 11/379132 [patent_app_country] => US [patent_app_date] => 2006-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 997 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615631.pdf [firstpage_image] =>[orig_patent_app_number] => 11379132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851805 [patent_doc_number] => 20060234996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Novel crystalline form of ezetimibe and processes for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 11/402962 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2365 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234996.pdf [firstpage_image] =>[orig_patent_app_number] => 11402962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142484 [patent_doc_number] => 20070004700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => '2-Thioethenyl substituted carbapenem derivatives' [patent_app_type] => utility [patent_app_number] => 11/401892 [patent_app_country] => US [patent_app_date] => 2006-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42324 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004700.pdf [firstpage_image] =>[orig_patent_app_number] => 11401892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5670251 [patent_doc_number] => 20060175605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Organometallic light-emitting material' [patent_app_type] => utility [patent_app_number] => 11/401537 [patent_app_country] => US [patent_app_date] => 2006-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5073 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20060175605.pdf [firstpage_image] =>[orig_patent_app_number] => 11401537 [rel_patent_id] =>[rel_patent_doc_number] =>)